Artificial intelligence (AI) models are increasingly reported in endocrine disease management, but clinical value cannot be inferred from discrimination, model complexity, or explainability alone. This narrative review synthesizes evidence from diabetes and diabetic kidney disease (DKD), thyroid disease, polycystic ova...